Rajesh P Shah1, Karen T Brown, Constantinos T Sofocleous. 1. Department of Radiology, Interventional Radiology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Ste H118, New York, NY 10065, USA.
Abstract
OBJECTIVE: Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. CONCLUSION: Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.
OBJECTIVE: Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. CONCLUSION: Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.
Authors: Olumide B Gbolahan; Michael A Schacht; Eric W Beckley; Thomas P LaRoche; Bert H O'Neil; Maximilian Pyko Journal: J Gastrointest Oncol Date: 2017-04
Authors: Natally Horvat; Ana I de Oliveira; Brunna Clemente de Oliveira; Jose A B Araujo-Filho; Maria El Homsi; Ahmed Elsakka; Raazi Bajwa; Guilherme L P Martins; Khaled M Elsayes; Marcos R Menezes Journal: Radiographics Date: 2022-10 Impact factor: 6.312
Authors: Mina S Makary; Stuart Ramsell; Eric Miller; Eliza W Beal; Joshua D Dowell Journal: World J Gastroenterol Date: 2021-11-21 Impact factor: 5.742